The Efficacy and Controversy of Octreotide and Somatostatin Analogues in the Treatment of Chronic Pancreatitis: A Review
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Chronic pancreatitis (CP) is a progressive fibro-inflammatory disease of the pancreas that causes chronic pain, maldigestion, endocrine insufficiency and frequent local complications such as pseudocysts and fistulae. Octreotide (a synthetic somatostatin analogue) and somatostatin reduce pancreatic exocrine secretion through somatostatin receptor–mediated mechanisms, and have been evaluated for symptom control, complication prevention and perioperative use in pancreatic surgery. Available data show biologically plausible effects (reduced pancreatic enzyme output and modulation of inflammation), clearer benefit in some acute and perioperative contexts (reduced postoperative pancreatic fistula in several trials), but heterogeneous and inconsistent results in chronic pancreatitis for long-term pain control and complication prevention
Fields of Study & Subjects
Pancreatitis Pathology and Treatment
Pancreatic and Hepatic Oncology Research
IgG4-Related and Inflammatory Diseases
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 March 2026
- Language
- EN